-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Concert Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2021.
- Concert Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$28.9M, a 8.34% decline year-over-year.
- Concert Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$126M, a 90.5% decline year-over-year.
- Concert Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$80.1M, a 7.07% decline from 2020.
- Concert Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$74.8M, a 4.35% increase from 2019.
- Concert Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2019 was -$78.2M, a 39.5% decline from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)